PHARMACOECONOMICS

Scope & Guideline

Transforming health economics for a sustainable future.

Introduction

Welcome to your portal for understanding PHARMACOECONOMICS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1170-7690
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1992 to 2024
AbbreviationPHARMACOECONOMICS / Pharmacoeconomics
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The journal 'PHARMACOECONOMICS' focuses on the economic evaluation of health technologies, aiming to inform healthcare decision-making through rigorous analysis and modeling. It emphasizes the integration of clinical effectiveness with economic implications, encouraging a multidisciplinary approach that encompasses health policy, pharmacoeconomics, and public health.
  1. Economic Evaluation of Health Technologies:
    The journal publishes studies that evaluate the cost-effectiveness of various health interventions, including pharmaceuticals, medical devices, and healthcare services, using methodologies such as cost-utility analysis, cost-effectiveness analysis, and budget impact analysis.
  2. Modeling Approaches in Health Economics:
    A significant focus is on the development and application of various modeling techniques, including Markov models, discrete event simulation, and probabilistic modeling, to assess long-term outcomes and economic impacts of health interventions.
  3. Patient-Centered Outcomes and Quality of Life:
    Research related to the measurement of health-related quality of life (HRQoL) and patient preferences is prominent. This includes studies on utility measures like EQ-5D and their application in economic evaluations.
  4. Real-World Evidence and Data Utilization:
    The journal encourages the use of real-world data to inform economic evaluations and policy decisions, emphasizing the relevance of real-world evidence in assessing the economic impact of interventions.
  5. Interdisciplinary Approaches to Health Economics:
    It promotes an interdisciplinary perspective, integrating insights from clinical research, epidemiology, health policy, and behavioral economics to enhance the depth and applicability of economic evaluations.
The journal 'PHARMACOECONOMICS' is adapting to contemporary healthcare challenges and evolving research methodologies. Recent publications indicate a strong focus on innovative approaches and emerging themes in health economics.
  1. Value-Based Healthcare and Pricing Models:
    There is a growing emphasis on value-based healthcare frameworks that assess the value of interventions in terms of outcomes relative to costs. This trend reflects the shift towards outcome-oriented pricing models in the healthcare industry.
  2. Equity and Social Determinants of Health:
    Research addressing health equity and the social determinants of health is gaining traction, emphasizing the importance of considering how economic evaluations can impact diverse populations and promote equitable healthcare access.
  3. Integration of Real-World Data:
    The use of real-world data in economic evaluations is on the rise, highlighting the importance of incorporating actual patient outcomes and resource utilization into cost-effectiveness analyses.
  4. Patient and Stakeholder Engagement:
    There is an increasing focus on involving patients and stakeholders in the economic evaluation process to better capture preferences and improve the relevance of health technologies to end-users.
  5. Innovative Methodological Approaches:
    Emerging methodologies, such as machine learning and advanced statistical techniques, are being applied to economic evaluations, enhancing the robustness and precision of analyses in complex healthcare environments.

Declining or Waning

While the journal continues to thrive in various areas, certain themes have shown a decline in prominence over recent years. This shift may reflect changing priorities in health economics and emerging challenges in the healthcare landscape.
  1. Traditional Cost-Effectiveness Analysis:
    There is a noticeable reduction in studies solely focused on traditional cost-effectiveness analysis without considering broader implications, such as equity or long-term societal impacts. This indicates a shift towards more comprehensive evaluation frameworks.
  2. Pharmacoeconomic Evaluations of Older Therapies:
    Research on older therapies appears to be declining as newer, more innovative treatments emerge. The focus is shifting towards assessing the economic impact of cutting-edge therapies and technologies rather than established treatments.
  3. Narrowly Focused Economic Models:
    The journal has seen fewer publications that rely on narrowly focused economic models with limited scope. There is now a trend towards more complex models that account for a variety of factors, including patient heterogeneity and real-world complexities.
  4. Sole Emphasis on Cost Minimization:
    Papers that primarily focus on cost minimization strategies without addressing the broader implications for health outcomes and quality of life are becoming less frequent, as the field moves towards more holistic evaluations.
  5. Regional Studies with Limited Generalizability:
    There is a waning interest in studies that focus exclusively on localized economic evaluations without consideration for broader applicability or generalizability to other settings or populations.

Similar Journals

HEALTH SERVICES RESEARCH

Exploring the intersection of health services and policy.
Publisher: WILEYISSN: 0017-9124Frequency: 6 issues/year

HEALTH SERVICES RESEARCH, published by Wiley, is a premier journal focused on advancing the field of health policy and services research. With an ISSN of 0017-9124 and an impressive E-ISSN of 1475-6773, this esteemed publication has been at the forefront of health services inquiry since its inception in 1966. Recognized as a Q1 journal in Health Policy for 2023, it ranks #80 out of 310 in Scopus, placing it in the 74th percentile, underlining its significant influence in the field. The journal caters to a global audience of researchers, practitioners, and students by providing a platform for rigorous empirical studies and critical reviews that aim to improve health care delivery and policy outcomes. Although it does not offer open access, the comprehensive articles and insights published within its pages are essential for anyone seeking to understand and influence health systems. With its convergence towards the year 2024, HEALTH SERVICES RESEARCH continues to be a vital resource for those dedicated to enhancing healthcare effectiveness and accessibility.

Global & Regional Health Technology Assessment

Innovating health solutions through critical assessment.
Publisher: ABOUTSCIENCE SRLISSN: 2284-2403Frequency: 1 issue/year

Global & Regional Health Technology Assessment (ISSN: 2284-2403; E-ISSN: 2283-5733) is an esteemed open-access journal published by ABOUTSCIENCE SRL, dedicated to the dissemination of research in the field of health technology assessment on a global and regional scale. Since its inception in 2014, this journal has focused on the critical evaluation of health technologies, providing invaluable insights into their efficacy, cost-effectiveness, and impact on healthcare systems. With an increasing emphasis on public health and policy implications, the journal encourages interdisciplinary research that bridges gaps between technological innovations and health outcomes. Despite its relatively recent establishment, it has made significant inroads with Scopus rankings reflecting the growing importance of health technology assessment in global health discourse. The journal welcomes contributions from researchers, professionals, and students, inviting them to engage in discussions that shape the future of health technology, with the aim of informing stakeholders and policymakers worldwide.

MEDICAL DECISION MAKING

Innovating methodologies for impactful medical research.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Journal of the American College of Clinical Pharmacy

Exploring innovative practices in pharmaceutical science.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

Value in Health Regional Issues

Innovating Health Policy with Regional Perspectives.
Publisher: ELSEVIERISSN: 2212-1099Frequency: 3 issues/year

Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.

Gesundheitsoekonomie und Qualitaetsmanagement

Fostering Excellence in Health Economics and Quality Management
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

Journal of Comparative Effectiveness Research

Transforming healthcare through evidence-based insights.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

International Journal of Healthcare Management

Driving excellence in healthcare through strategic insights.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2047-9700Frequency: 4 issues/year

The International Journal of Healthcare Management, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, stands as a crucial platform for the dissemination of innovative research and insights in the realm of healthcare management. With a focus on health policy, leadership, and management, this journal aims to bridge the gap between theory and practice, providing a valuable resource for researchers, professionals, and students alike. It boasts an impressive Q2 ranking in Leadership and Management and a Q3 ranking in Health Policy for 2023, highlighting its influence and relevance within the academic community. With an accessible ISSN of 2047-9700 and E-ISSN of 2047-9719, the journal features an array of peer-reviewed articles that promote the advancement of knowledge and best practices in healthcare settings. While currently not offered as open access, the journal publishes high-quality research that underscores the importance of effective management strategies in enhancing healthcare outcomes. Positioned in the United Kingdom, the journal continues to contribute significant knowledge and frameworks that guide healthcare leaders and policymakers in navigating the complexities of governance in health services.

Exploratory Research in Clinical and Social Pharmacy

Bridging gaps in pharmacy practice with cutting-edge insights.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

ClinicoEconomics and Outcomes Research

Bridging Economics and Healthcare for Impactful Solutions
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6981Frequency: 1 issue/year

ClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!